Sintilimab maintenance therapy post first-line cytokine-induced killer cells plus chemotherapy for extensive-stage small cell lung cancer

Despite recent progress in treating advanced non-small cell lung cancer, clinical intervention in extensive-stage small-cell lung cancer (ES-SCLC) remains stagnant. The purpose of this study was to evaluate the clinical efficacy of cytokine-induced killer (CIK) cells combined with cytotoxic chemothe...

Descripción completa

Detalles Bibliográficos
Autores principales: Ma, Baozhen, Zhou, Yu, Shang, Yiman, Zhang, Yong, Xu, Benling, Fu, Xiaomin, Guo, Jindong, Yang, Yonghao, Zhang, Fang, Zhou, Mengyuan, Huang, Hao, Li, Fanghui, Lin, Hongwei, Zhao, Lingdi, Wang, Zibing, Gao, Quanli
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Oncology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9507303/
https://www.ncbi.nlm.nih.gov/pubmed/36158690
http://dx.doi.org/10.3389/fonc.2022.852885

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9507303/
https://www.ncbi.nlm.nih.gov/pubmed/36158690
http://dx.doi.org/10.3389/fonc.2022.852885

Ejemplares similares